Showing results (281-290 of 435) with videos related to
Sort By:
Pageof 44
Schizophrenia Research|September 11, 2010
Cognitive and symptomatic predictors of functional disability in schizophreniaSyed Shamsi, Adam Lau, Todd Lencz, et al.Journal of Clinical Psychopharmacology|June 21, 2016
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective DisorderDong-Jing Fu, Ibrahim Turkoz, R Bruce Simonson, et al.Brain Stimulation|October 15, 2018
Transcranial direct-current stimulation in ultra-treatment-resistant schizophreniaJ P Lindenmayer, Mila Kirstie C Kulsa, Tania Sultana, et al.Ecology Letters|August 24, 2006
A new method for conservation planning for the persistence of multiple speciesEmily Nicholson, Michael I Westphal, Karin Frank, et al.Journal of Clinical Psychopharmacology|July 31, 2001
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trialJ P Lindenmayer, J Volavka, J Lieberman, et al.Plos One|January 26, 2013
Habitat selection and behaviour of a reintroduced passerine: linking experimental restoration, behaviour and habitat ecologyVictoria A Bennett, Veronica A J Doerr, Erik D Doerr, et al.Global Change Biology|May 14, 2022
Fencing farm dams to exclude livestock halves methane emissions and improves water qualityMartino E Malerba, David B Lindenmayer, Ben C Scheele, et al.Environmental Monitoring and Assessment|August 22, 2022
Eight things you should never do in a monitoring program: an Australian perspectiveDavid B Lindenmayer, John Woinarski, Sarah Legge, et al.Journal of Clinical Psychopharmacology|May 20, 2024
Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive DyskinesiaChristoph U Correll, Leslie Citrome, Carlos Singer, et al.Schizophrenia Research|March 3, 2009
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorderRobert C Smith, Jean-Pierre Lindenmayer, John M Davis, et al.Pageof 44